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Abstract
Introduction:  Pulmonary artery sarcomas are rare neoplasms that are often confused with
chronic thrombo-embolic disease, as both can have similar clinical and imaging presentation.
Case presentation: In this report, we present a case of a 50-year-old man initially diagnosed with
chronic thrombo-embolic pulmonary disease, but who was later found to have pulmonary artery
sarcoma with poor survival prognosis. We review the clinical and imaging characteristics of the two
diseases and discuss the difficulties in establishing a timely diagnosis.
Conclusion: Similar clinical features and imaging presentation of pulmonary artery sarcoma and
chronic thrombo-embolic pulmonary disease make definitive diagnosis difficult. This case report
also illustrates and emphasizes that in any case with no predisposition factors for embolism, no
evidence of deep venous thrombosis and pulmonary emboli, and inadequate relief of symptoms
with anticoagulation, an alternative diagnosis of pulmonary artery sarcoma should be considered.
If pulmonary artery sarcoma is diagnosed late in the course of the disease, there is usually a poor
survival outcome.
Introduction
Pulmonary artery sarcoma is a rare tumor of the cardiovas-
cular system. Because of its rarity and insidious growth, it
is often mistaken for pulmonary embolism [1,2]. Clinical
symptoms, as well as imaging characteristics often associ-
ated with pulmonary embolism, are also very common in
patients with pulmonary artery sarcoma which, in many
instances, delays the correct diagnosis. [3-6]. We present a
case of a man who experienced a thrombus in the main
pulmonary artery and was later diagnosed with pulmo-
nary artery sarcoma with poor survival outcome.
Case presentation
A 50-year-old man was admitted to our clinic with a 20-
day history of cough, small amounts of haemoptysis, fever
and exhaustion. There was no past medical history of pre-
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disposition factors for embolism or episodes of venous
thrombo-embolism.
During the hospitalization, the patient developed a mas-
sive haemoptysis. Laboratory blood tests showed elevated
inflammatory parameters, but platelets and plasma coag-
ulation function parameters were in the normal range:
platelet: 254 × 109/L; fibrinogen: 278 mg/dl; bleeding
time, Duke methods: < 4 minutes; partial thromboplasin
time: 29 seconds; prothrombin time: 12.7 seconds;
thrombin time: 17 seconds; protein C: 121%; protein S:
93%. A computerized tomography (CT) scan of the lungs
showed a few areas of pulmonary consolidation on the
right side and a few enlarged mediastinal lymph nodes
(Figure 1). The presumptive fibre optic bronchoscopy
findings were bronchogenic carcinoma; however, his-
topathological findings did not confirm a malignancy.
The patient was given symptomatic therapy which led to
a complete clinical recovery, and he was discharged with
follow-up recommended.
Two months later the patient developed intensive chest
pain, medium amounts of haemoptysis and fever. Labora-
tory tests showed three-fold elevated inflammatory
parameters and D-dimer value. Chest radiography was
significant since it showed prominent parenchymal den-
sity in the lateral right low-lung field as well as heart
enlargement. On CT scan (Figure 2), we identified differ-
ent locations of pulmonary consolidation and pleural
thickening on the right side, as well as a dilated pulmo-
nary artery trunk. Venous duplex ultrasound of the lower
extremities was negative for deep-vein thrombosis. How-
ever, echosonography showed right ventricular hypertro-
phy; perfusion scintigraphy uncovered a complete
absence of the perfusion of the right lung, and pulmonary
angiography (Figure 3) showed a complete occlusion of
the right pulmonary artery due to external compression or
intra-luminal infiltration. The patient was placed on low-
density heparin for a presumptive diagnosis of pulmonary
embolism. There were no further episodes of haemopty-
sis, and the patient was discharged with a recommended
anticoagulant therapy.
A further 6 months later, despite the anticoagulant ther-
apy treatment, the patient developed massive haemopty-
sis. Transoesophageal echosonography showed a mass in
the pulmonary trunk. On the basis of contrast-enhanced
CT scan (Figure 4) and magnetic resonance imaging
(MRI) (Figure 5) of the heart and blood vessels showing a
large filling defect in the pulmonary artery trunk and in
the right branch, massive pulmonary embolism was diag-
nosed. A right dorsal posterior pleural effusion was noted
and 25 ml of haemorrhage pleural fluid was drained.
The patient underwent surgery with embolectomy of a
suspected thrombotic mass in the pulmonary trunk; how-
ever, histopathology revealed an angiosarcoma of the pul-
monary artery. He was haemodynamically unstable, and
due to respiratory insufficiency, invasive mechanical ven-
tilation had to be carried out. Three weeks later, he died
due to heart and lung failure.
Computerized tomography scan of the lung: a few areas of  pulmonary consolidation on the right side and a few enlarged  mediastinal lymph nodes can be seen Figure 1
Computerized tomography scan of the lung: a few 
areas of pulmonary consolidation on the right side 
and a few enlarged mediastinal lymph nodes can be 
seen.
Computerized tomography scan of the lung showing different  locations of pulmonary consolidation and pleural thickening  on the right side and dilated pulmonary artery trunk Figure 2
Computerized tomography scan of the lung showing 
different locations of pulmonary consolidation and 
pleural thickening on the right side and dilated pul-
monary artery trunk.Journal of Medical Case Reports 2009, 3:64 http://www.jmedicalcasereports.com/content/3/1/64
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Discussion
Pulmonary artery sarcoma is a rare tumor of the cardiovas-
cular system. The reported age for its appearance ranges
from 13 to 86 years of age, with the majority of cases
occurring in middle age. The aetiology of these tumors is
obscure. It has been suggested that they arise from the
mesenchymal cells of the muscle angle of the bulbus
cordis. The most frequent histopathological type is leio-
myosarcoma or "undifferentiated spindle-cell sarcoma".
Angiosarcoma accounts for 7% of cases. The histopatho-
logical classification does not seem to be useful clinically
or prognostically [1,2].
Because of its rarity and insidious growth characteristics,
pulmonary artery sarcoma is often mistaken for pulmo-
nary embolism, leading to inappropriate therapy such as
prolonged anticoagulation or thrombolysis [1]. The
symptoms often associated with pulmonary embolism
can be present in patients with pulmonary artery sarcoma
[1,3,7], including sudden onset of chest pain, dyspnoea
and haemoptysis, cough or right-heart failure. However,
patients with pulmonary artery sarcoma generally experi-
ence a slowly progressing decline over several weeks or
Pulmonary angiography showing a large filling defect causing  complete obstruction of the right pulmonary artery Figure 3
Pulmonary angiography showing a large filling defect 
causing complete obstruction of the right pulmonary 
artery.
Contrast-enhanced computerized tomography scan of large  blood vessels showing a large filling defect in the pulmonary  artery trunk and in one-third of the left main pulmonary  artery, as well as a complete occlusion of the right branch  due to emboli or some infiltrative mass Figure 4
Contrast-enhanced computerized tomography scan 
of large blood vessels showing a large filling defect in 
the pulmonary artery trunk and in one-third of the 
left main pulmonary artery, as well as a complete 
occlusion of the right branch due to emboli or some 
infiltrative mass.
Contrast-enhanced magnetic resonance image of the large  blood vessels showing a large filling defect in the pulmonary  artery trunk and complete occlusion of the right branch with  a discreet increase in signal intensity after contrast injection  (arrows) Figure 5
Contrast-enhanced magnetic resonance image of the 
large blood vessels showing a large filling defect in 
the pulmonary artery trunk and complete occlusion 
of the right branch with a discreet increase in signal 
intensity after contrast injection (arrows).Journal of Medical Case Reports 2009, 3:64 http://www.jmedicalcasereports.com/content/3/1/64
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months, characterized by symptoms of weight loss, fever
and severe fatigue, as commonly seen in malignancy [8].
The symptoms observed in our patient were related to the
infiltration or invasion of the adjacent bronchus, which
lead to the initial presumed diagnosis of bronchogenic
carcinoma.
Laboratory studies are of little value in establishing the
diagnosis. It is not uncommon to observe anaemia or an
elevated erythrocyte sedimentation rate [3]; we also found
elevated inflammatory parameters, which are non-specific
findings. These findings are unusual in pulmonary embo-
lism.
Pulmonary artery sarcoma develops within the pulmo-
nary trunk or pulmonary valve region and is frequently
associated with a multicentric origin in the outflow track
of the right ventricle. Also, perfusion defects remain static
or progressive over time rather than changing with fibri-
nolysis or recurring, as one might expect in thrombo-
embolic disease [3]. Approximately 40% of patients
develop a direct invasion or metastasis to the lung, while
systemic spread to kidneys, brain or adrenal glands occurs
in about 20% of cases [3,9].
Chest radiographic findings are varied. The most common
finding is an abnormal hilar shadow that has the appear-
ance of an enlarged pulmonary artery or mass projecting
into the lung parenchyma. Other common findings are
pulmonary consolidation, atelectasis or pulmonary nod-
ules or masses, presumably the result of the embolic phe-
nomenon with or without infarction or metastases in the
lungs [8,10]. Pleural effusion, usually haemorrhagic with
normal cytological findings, is a common finding [8] and
was also observed in our patient.
However, in pulmonary thrombo-embolic disease, imag-
ing changes are most likely bilateral or recurrent, depend-
ing on the aetiology and therefore on the direction of
blood flow and distribution of emboli [5,6,11].
In our case, despite anticoagulation, the imaging features
remained persistent. Furthermore, a unilateral central pul-
monary embolus is relatively uncommon and suggests a
possibility of malignancy [4-7].
Pulmonary artery sarcoma and chronic thrombo-embolic
pulmonary disease can be easily confused on CT or MRI
scan, because both are characterized by intra-luminal fill-
ing defects and pulmonary arterial dilatation [4,7]. How-
ever, there are radiographic criteria that may help
differentiate the two entities. CT findings consistent with
malignancy include filling defects occupying the entire
luminal diameter of the pulmonary arteries and extra-
luminal extension of the tumor. In addition, pulmonary
artery sarcomas may be indicated by areas of inhomoge-
neous, high or low attenuation, representing haemor-
rhage or necrosis, soft-tissue density in pulmonary
arteries, or enhancement after administration of gadopen-
tetate dimeglumine on the MRI [4,7]. Gadolinium-
enhanced MRI is another potentially useful diagnostic
tool in differentiating between intra-luminal tumors and
large thrombi [4,7,12].
There are no specific findings on echosonography, per-
fusion lung scan or pulmonary angiography perfusion
lung scan that would reliably differentiate embolic
obstruction from obstruction caused by a tumour, with
the exception of commonly static perfusion defects and a
positive gallium scan in the cases of sarcomatous obstruc-
tion [3,4,12].
In cases of pulmonary artery sarcoma, early diagnosis and
radical surgical resection offer the only opportunity for
prolonged survival [1,13], with only three cases reported
to survive for longer than 3 years. Surgical resection
increases the chances of survival by approximately 12
months, and there is limited evidence that this may be fur-
ther extended by neo-adjuvant and/or adjuvant irradia-
tion and chemotherapy [14,15]. The role of radiation
therapy and postoperative anticoagulation therapy is still
not clearly defined [1,9]. For patients with extensive medi-
astinal involvement or metastatic disease, limited tumour
resection or bypass procedure may offer significant pallia-
tion benefit and enhance survival. The prognosis is
mainly dependent on local recurrence. The average time
of survival without an intervention is 6 weeks [7,14].
In our case, a diagnosis was established too late, the dis-
ease was in an advanced stage and there was no appropri-
ate therapy modality.
Conclusion
Our case illustrates and emphasizes that pulmonary artery
sarcoma should be included in the differential diagnosis
of pulmonary thrombo-embolic disease in cases where: a)
symptoms do not respond to anticoagulation, b) no
source of thrombi and emboli can be detected, and c) pul-
monary nodules and/or metastases develop on follow-up.
If pulmonary artery sarcoma is diagnosed after the occur-
rence of distal metastases or involvement of adjacent
mediastinal structure, there is a poor survival outcome.
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